Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm
- PMID: 22958421
- PMCID: PMC3485169
- DOI: 10.1186/1471-2180-12-196
Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm
Abstract
Background: Biofilm production is an important mechanism for bacterial survival and its association with antimicrobial resistance represents a challenge for the patient treatment. In this study we evaluated the in vitro action of macrolides in combination with anti-pseudomonal agents on biofilm-grown Pseudomonas aeruginosa recovered from cystic fibrosis (CF) patients.
Results: A total of 64 isolates were analysed. The biofilm inhibitory concentration (BIC) results were consistently higher than those obtained by the conventional method, minimal inhibitory concentration, (MIC) for most anti-pseudomonal agents tested (ceftazidime: P = 0.001, tobramycin: P = 0.001, imipenem: P < 0.001, meropenem: P = 0.005). When macrolides were associated with the anti-pseudomonal agents, the BIC values were reduced significantly for ceftazidime (P < 0.001) and tobramycin (P < 0.001), regardless the concentration of macrolides. Strong inhibitory quotient was observed when azithromycin at 8 mg/L was associated with all anti-pseudomonal agents tested in biofilm conditions.
Conclusions: P. aeruginosa from CF patients within biofilms are highly resistant to antibiotics but macrolides proved to augment the in vitro activity of anti-pseudomonal agents.
Figures
Similar articles
-
In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.Int J Antimicrob Agents. 2012 Aug;40(2):173-6. doi: 10.1016/j.ijantimicag.2012.04.006. Epub 2012 Jun 21. Int J Antimicrob Agents. 2012. PMID: 22727530
-
Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.Antimicrob Agents Chemother. 2017 Dec 21;62(1):e01650-17. doi: 10.1128/AAC.01650-17. Print 2018 Jan. Antimicrob Agents Chemother. 2017. PMID: 29084746 Free PMC article.
-
Advances toward the elucidation of hypertonic saline effects on Pseudomonas aeruginosa from cystic fibrosis patients.PLoS One. 2014 Feb 28;9(2):e90164. doi: 10.1371/journal.pone.0090164. eCollection 2014. PLoS One. 2014. PMID: 24587256 Free PMC article.
-
Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.Treat Respir Med. 2005;4(4):241-53. doi: 10.2165/00151829-200504040-00003. Treat Respir Med. 2005. PMID: 16086598 Review.
-
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.Cochrane Database Syst Rev. 2017 Oct 5;10(10):CD009528. doi: 10.1002/14651858.CD009528.pub4. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jun 10;6:CD009528. doi: 10.1002/14651858.CD009528.pub5. PMID: 28981972 Free PMC article. Updated. Review.
Cited by
-
Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn's disease (CD): protocol of a pilot study.BMJ Open. 2023 Feb 1;13(2):e064944. doi: 10.1136/bmjopen-2022-064944. BMJ Open. 2023. PMID: 36725090 Free PMC article.
-
The Status of Carbapenem Resistance in Cystic Fibrosis: A Systematic Review and Meta-Analysis.Yale J Biol Med. 2022 Dec 22;95(4):495-506. eCollection 2022 Dec. Yale J Biol Med. 2022. PMID: 36568834 Free PMC article. Review.
-
Innovative Perspectives on Biofilm Interactions in Poultry Drinking Water Systems and Veterinary Antibiotics Used Worldwide.Antibiotics (Basel). 2022 Jan 9;11(1):77. doi: 10.3390/antibiotics11010077. Antibiotics (Basel). 2022. PMID: 35052954 Free PMC article.
-
Synergy between Indoloquinolines and Ciprofloxacin: An Antibiofilm Strategy against Pseudomonas aeruginosa.Antibiotics (Basel). 2021 Oct 4;10(10):1205. doi: 10.3390/antibiotics10101205. Antibiotics (Basel). 2021. PMID: 34680786 Free PMC article.
-
Effect of azithromycin and phenylalanine-arginine beta-naphthylamide on quorum sensing and virulence factors in clinical isolates of Pseudomonas aeruginosa.Iran J Microbiol. 2021 Feb;13(1):37-49. doi: 10.18502/ijm.v13i1.5491. Iran J Microbiol. 2021. PMID: 33889361 Free PMC article.
References
-
- Staab D. Cystic fibrosis - therapeutic challenge in cystic fibrosis children. Eur J Endocrinol. 2004;151(Suppl 1):S77–S80. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical